Tiengo A - Search Results

1

Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients.

Bruttomesso D, Fongher C, Silvestri B, Barberio S, Marescotti MC, Iori E, Valerio A, Crazzolara D, Pianta A, Tiengo A, Del Prato S. Bruttomesso D, et al. Among authors: tiengo a. Diabetes Res Clin Pract. 2001 Feb;51(2):97-105. doi: 10.1016/s0168-8227(00)00210-2. Diabetes Res Clin Pract. 2001. PMID: 11165689 Clinical Trial.

2

Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment.

Avogaro A, Valerio A, Gnudi L, Maran A, Zolli M, Duner E, Riccio A, Del Prato S, Tiengo A, Nosadini R. Avogaro A, et al. Among authors: tiengo a. Diabetes. 1992 Aug;41(8):968-74. doi: 10.2337/diab.41.8.968. Diabetes. 1992. PMID: 1628772 Clinical Trial.

3

No effects of high-fiber diets on metabolic control and insulin-sensitivity in type 1 diabetic subjects.

Bruttomesso D, Biolo G, Inchiostro S, Fongher C, Briani G, Duner E, Marescotti MC, Iori E, Tiengo A, Tessari P. Bruttomesso D, et al. Among authors: tiengo a. Diabetes Res Clin Pract. 1991 Aug;13(1-2):15-21. doi: 10.1016/0168-8227(91)90028-c. Diabetes Res Clin Pract. 1991. PMID: 1663445

4

Effects of different insulin administrations on plasma amino acid profile in insulin-dependent diabetic patients.

Trevisan R, Marescotti C, Avogaro A, Tessari P, del Prato S, Tiengo A. Trevisan R, et al. Among authors: tiengo a. Diabetes Res. 1989 Oct;12(2):57-62. Diabetes Res. 1989. PMID: 2699443

5

The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines.

Tiengo A, Del Prato S. Tiengo A, et al. Diabetes Res Clin Pract. 1988;4 Suppl 1:75-81. doi: 10.1016/0168-8227(88)90019-8. Diabetes Res Clin Pract. 1988. PMID: 3042339 No abstract available.

6

Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action.

Vigili de Kreutzenberg S, Riccio A, Dorella M, Avogaro A, Marescotti MC, Tiengo A, del Prato S. Vigili de Kreutzenberg S, et al. Among authors: tiengo a. Eur J Clin Invest. 1995 May;25(5):360-7. doi: 10.1111/j.1365-2362.1995.tb01714.x. Eur J Clin Invest. 1995. PMID: 7628524

7

Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.

Riccio A, Avogaro A, Valerio A, Zappella A, Tiengo A, Del Prato S. Riccio A, et al. Among authors: tiengo a. Diabetes Care. 1994 Jun;17(6):535-40. doi: 10.2337/diacare.17.6.535. Diabetes Care. 1994. PMID: 8082521 Clinical Trial.

8

Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.

Trevisan R, Bruttomesso D, Vedovato M, Brocco S, Pianta A, Mazzon C, Girardi C, Jori E, Semplicini A, Tiengo A, Del Prato S. Trevisan R, et al. Among authors: tiengo a. Diabetes. 1998 Aug;47(8):1347-53. doi: 10.2337/diab.47.8.1347. Diabetes. 1998. PMID: 9703338

9

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S. Bruttomesso D, et al. Among authors: tiengo a. Diabetes. 1999 Jan;48(1):99-105. doi: 10.2337/diabetes.48.1.99. Diabetes. 1999. PMID: 9892228

10

The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.

Del Prato S, Tiengo A. Del Prato S, et al. Among authors: tiengo a. Diabetes Metab Res Rev. 2001 May-Jun;17(3):164-74. doi: 10.1002/dmrr.198. Diabetes Metab Res Rev. 2001. PMID: 11424229 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters